ZBTB7A and glioblastoma: In this study, we confirmed that the expression of ZBTB7A was very low in GBM through the analysis of The Cancer Genome Atlas (TCGA) dataset, and the decreased expression of ZBTB7A was correlated with lower survival rates of GBM.